A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing ...
2don MSN
Study: Tirzepatide improves blood sugar control in children with poorly controlled type 2 diabetes
New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood ...
15don MSN
Diabetes Type 2 treatment: This diet reduces risk of diabetes better than only low-fat diet
Diabetes Type 2 diet is a major concern. A new research study has shown that Mediterranean diet is helpful in reducing the risk of Diabetes Type 2.
Diabetes type 2, can be caused by obesity and occurs when adults become resistant to the hormone insulin. Type 1 diabetes, ...
For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But with the growing popularity and effectiveness of medications like semaglutide ...
A Japanese study links external eating patterns to weight loss and glycemic improvements with glucagon-like peptide-1 receptor agonists.
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
Although type 2 diabetes is often regarded as a disease of ageing, cases of type 2 diabetes in children and adolescents have ...
Latent autoimmune diabetes in adults (Lada), often called Type 1.5 diabetes, is a lesser-known condition that is frequently ...
Adults with type 2 diabetes and obstructive sleep apnea who use continuous positive airway pressure may reduce their risk for ...
News-Medical.Net on MSN
CPAP treatment may reduce death risk in people with both type 2 diabetes and sleep apnea
People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous ...
MedPage Today on MSN
JAK Inhibitor Benefits in Type 1 Diabetes Lost After Discontinuation
The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results